Literature DB >> 20134354

Role of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression.

Bethany L Fitzsimmons1, Michela Zattoni, Camilla I Svensson, Joanne Steinauer, Xiao-Ying Hua, Tony L Yaksh.   

Abstract

Pharmacological studies indicate that spinal p38 mitogen-activated protein kinase plays a role in the development of hyperalgesia. We investigated whether either the spinal isoform p38alpha or p38beta is involved in peripheral inflammation evoked pain state and increased expression of spinal COX-2. Using intrathecal antisense oligonucleotides, we show that hyperalgesia is prevented by downregulation of p38beta but not p38alpha, whereas increases in spinal COX-2 protein expression at 8 hours are mediated by both p38alpha and beta isoforms. These data suggest that early activation of spinal p38beta isoform may affect acute facilitatory processing, and both p38beta and alpha isoforms mediate temporally delayed upregulation of spinal COX-2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134354      PMCID: PMC2877130          DOI: 10.1097/WNR.0b013e32833774bf

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression.

Authors:  Chun Kim; Yasuyo Sano; Kristina Todorova; Bradley A Carlson; Luis Arpa; Antonio Celada; Toby Lawrence; Kinya Otsu; Janice L Brissette; J Simon C Arthur; Jin Mo Park
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

Review 2.  The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing.

Authors:  Camilla I Svensson; Tony L Yaksh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

3.  Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Authors:  T A Samad; K A Moore; A Sapirstein; S Billet; A Allchorne; S Poole; J V Bonventre; C J Woolf
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

Review 4.  In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance.

Authors:  Yu Shi; Matthias Gaestel
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

5.  Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice.

Authors:  H Gühring; M Görig; M Ates; O Coste; H U Zeilhofer; A Pahl; K Rehse; K Brune
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB.

Authors:  B L Fiebich; B Mueksch; M Boehringer; M Hüll
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

7.  Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators.

Authors:  Karsten Schroer; Ying Zhu; Michael A Saunders; Wu-Guo Deng; Xiao-Ming Xu; Jutta Meyer-Kirchrath; Kenneth K Wu
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

8.  Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia.

Authors:  Camilla I Svensson; Xiao-Ying Hua; Andrew A Protter; Henry C Powell; Tony L Yaksh
Journal:  Neuroreport       Date:  2003-06-11       Impact factor: 1.837

9.  Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR.

Authors:  Kotha Subbaramaiah; Timothy P Marmo; Dan A Dixon; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2003-06-25       Impact factor: 5.157

10.  Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing.

Authors:  Camilla I Svensson; Martin Marsala; Anna Westerlund; Nigel A Calcutt; Wendy M Campana; Jason D Freshwater; Rosanne Catalano; Ying Feng; Andrew A Protter; Brian Scott; Tony L Yaksh
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

View more
  14 in total

1.  A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha.

Authors:  Haijun Zhang; Hui Nei; Patrick M Dougherty
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

2.  MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.

Authors:  Francisco A Aguilar-Alonso; José D Solano; Chabetty Y Vargas-Olvera; Ignacio Pacheco-Bernal; Telma O Pariente-Pérez; María Elena Ibarra-Rubio
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

3.  NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain.

Authors:  Donghoon Kim; Byunghyun You; Eun-Kyeong Jo; Sang-Kyou Han; Melvin I Simon; Sung Joong Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.

Authors:  Xin Luo; Bethany Fitzsimmons; Apoorva Mohan; Linlin Zhang; Niccolo Terrando; Holly Kordasiewicz; Ru-Rong Ji
Journal:  Brain Behav Immun       Date:  2017-11-08       Impact factor: 7.217

Review 5.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

6.  Inhibitory effects of intrathecal p38β antisense oligonucleotide on bone cancer pain in rats.

Authors:  Hang Dong; Hong-Bing Xiang; Da-Wei Ye; Xue-Bi Tian
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 7.  Antisense Drugs Make Sense for Neurological Diseases.

Authors:  C Frank Bennett; Holly B Kordasiewicz; Don W Cleveland
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-09       Impact factor: 13.820

Review 8.  The search for novel analgesics: targets and mechanisms.

Authors:  Tony L Yaksh; Sarah A Woller; Roshni Ramachandran; Linda S Sorkin
Journal:  F1000Prime Rep       Date:  2015-05-26

9.  Deficiency in p38β MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse models.

Authors:  Bin Xing; Adam D Bachstetter; Linda J Van Eldik
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

10.  Intervention of electroacupuncture on spinal p38 MAPK/ATF-2/VR-1 pathway in treating inflammatory pain induced by CFA in rats.

Authors:  Jian-Qiao Fang; Jun-Ying Du; Yi Liang; Jun-Fan Fang
Journal:  Mol Pain       Date:  2013-03-22       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.